The Kenya Neurology Clinical Trials market is projected to grow from $3.66 Mn in 2022 to $6.1 Mn by 2030, registering a CAGR of 6.6% during the forecast period of 2022 - 2030. The market will be driven by investments in healthcare infrastructure by the Kenyan government and a favourable regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Merck & Co., Inc., Novartis International AG, and Roche Holding AG.
The Kenya Neurology Clinical Trials market is projected to grow from $3.66 Mn in 2022 to $6.1 Mn by 2030, registering a CAGR of 6.6% during the forecast period of 2022 - 2030. According to the International Finance Corporation (IFC), Sub-Saharan Africa has 11% of the world's population but bears 24% of the global illness burden in terms of human and financial expenses. Africa accounts for over half of all child fatalities under the age of five. Noncommunicable diseases (NCDs) account for 37% of DALYs in Kenya, with neurological illnesses accounting for 70%. Alzheimer's and dementia fatalities in Kenya reached 1,827 in 2020, accounting for 0.69% of total deaths, according to the most recent WHO statistics. Kenya ranks 76 in the world with an age-adjusted death rate of 18.35 per 100,000 inhabitants.
Kenya's neurology clinical trial landscape is still in its early phases, with minimal clinical trial activity focusing on neurological illnesses. Historically, the bulk of clinical trials in Kenya has focused on infectious illnesses and non-communicable diseases such as cancer, cardiovascular disease, and diabetes. The low frequency of neurological illnesses in Kenya is one of the reasons for the country's minimal clinical trial activity in neurology.
The rising prevalence of neurological illnesses in Kenya, such as stroke, epilepsy, and Parkinson's disease, is spurring interest in clinical studies in this sector. Kenya's government and academic institutions are starting to invest in research infrastructure and training to support neurological clinical trial activities. Nairobi's Aga Khan University Hospital has begun a neurology research programme that includes clinical trials for neurological illnesses. Moreover, the Kenya Medical Research Institute (KEMRI) has begun to investigate options for conducting neurology clinical trials and has cooperated with global counterparts to establish clinical trial protocols.
Market Growth Drivers
Many aspects influence neurology clinical trials in Kenya, including the country's high incidence of neurological illnesses such as epilepsy, stroke, and neuro infections. Moreover, the Kenyan government has invested in the healthcare system, including the establishment of specialist neurological care clinics, which may draw additional clinical trials to the nation. The favourable regulatory framework in Kenya, which includes the formation of regulatory agencies such as the Pharmacy and Poisons Board (PPB) and the National Commission for Science, Technology, and Innovation (NACOSTI), also contributes to the country's adoption of clinical trials.
There are a number of obstacles to conducting clinical trials in Kenya. One of them is the country's inadequate research funding, which may impede the expansion of clinical trials. Moreover, a dearth of skilled people, such as neurologists and clinical trial coordinators, may impede the conduct of high-quality studies. Insufficient infrastructure, particularly clinical research and laboratory facilities, is another barrier. Moreover, there may be ethical considerations with clinical trial conduct in Kenya, such as informed consent and participant safety.
March 2022, Roche planned to submit findings from its extensive and significant neuroscience portfolio at the 2022 AAN Annual Conference.
The Pharmaceutical and Poisons Board (PPB) and the National Council for Science, Technology, and Innovation govern and monitor clinical research in Kenya (NACOSTI). Kenya's PPB is the regulatory body responsible for clinical trial approvals, supervision, and inspections, according to the Pharmacy and Poisons Act (PPA), the Pharmacy and Poisons (Conduct of Clinical Trials) Rules (CTRules), and the Guidelines for the Conduct of Clinical Trials in Kenya (G-KenyaCT. The PPB and its Expert Committee on Clinical Trials (ECCT) assess all clinical trial-related issues and provide approval for clinical trials to be undertaken in Kenya.
1. Report Description of the Kenya Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Kenya Neurology Clinical Trials Market Executive Summary
2.1 Kenya Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Kenya Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Kenya Neurology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Study Design Outlook
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.3 By Indication Outlook
4.3.3 Expanded Access
5. Kenya Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Kenya
8.2 Regulatory Framework in Kenya
8.3 Pricing & Reimbursement Scenario in Kenya Neurology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development Kenya Neurology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses